CLINICAL TRIALS PROFILE FOR OLOPATADINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for olopatadine hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00331500 ↗ | Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis | Completed | Alcon Research | Phase 3 | 2006-04-18 | The purpose of this study is to demonstrate that Olopatadine 0.2% is superior to vehicle in the treatment of the signs and symptoms associated with allergic conjunctivitis or rhinoconjunctivitis. |
NCT00389025 ↗ | Mast-Cell Stabilizing Effects of Olopatadine | Completed | Alcon Research | Phase 4 | 2006-10-01 | To assess the effects of olopatadine of the release of mast cell histamine |
NCT00489398 ↗ | Comparison of CL Wear Between Two Allergy Drops | Withdrawn | Merck Sharp & Dohme Corp. | Phase 4 | 2007-07-01 | Comparison of two allergy drops for enhancing comfort and performance of contact lens wear |
NCT00489398 ↗ | Comparison of CL Wear Between Two Allergy Drops | Withdrawn | Hom, Milton M., OD, FAAO | Phase 4 | 2007-07-01 | Comparison of two allergy drops for enhancing comfort and performance of contact lens wear |
NCT00578331 ↗ | Safety Study of Olopatadine Nasal Spray | Completed | Alcon Research | Phase 3 | 2006-12-01 | The purpose of this study is to determine whether olopatadine nasal spray is safe and effective when used for up to one year by patients with perennial allergic rhinitis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for olopatadine hydrochloride
Condition Name
Clinical Trial Locations for olopatadine hydrochloride
Trials by Country
Clinical Trial Progress for olopatadine hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for olopatadine hydrochloride
Sponsor Name